2010 San Diego Chinese American Association Events


Introducing The Dragon Boat Festival(端午节)at North University Community Branch Library, Jun 12, 2010

and more ...
If you want to introduce more program, please contact Simon Fang(方向明 This email address is being protected from spambots. You need JavaScript enabled to view it.) or XingJian Liu(刘兴坚 This email address is being protected from spambots. You need JavaScript enabled to view it.).
Duan Wu Jie



The 9th Annual Symposium on Biopharmaceuticals - San Diego Bio-Pharma Conference 2010

  • Organizers: Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA)
    San Diego Chinese American Association
  • Co-organizers: The American Chemical Society, San Diego Section (ACS-SD)
    UCSD Technology Transfer and Intellectual Property Services (UCSD TTIPS)
  • Organizing community:
Robin Allgren, M.D., Ph.D, Breakthrough Bio Development
Hui Cai, Ph.D., MBA, Wuxi Apptech
Xiangming Fang, M.D., Ph.D., eBioCenter
Gensheng Feng, Ph.D., UCSD
Ming Guo, Ph.D., Ascenta Therapeutics
David Jiang, Ph.D.
Hui Li, Ph.D., Pfizer
Shuyan Lu, Ph.D., Pfizer
Mao Mao, Ph.D. Pfizer
Feng Tian, Ph.D.
Mingzhu Zhang, Ph.D., Medicilon
Peter Zhu, Ph.D., Pfizer
  • Description and Program

Into its ninth year, this annual symposium strives to strengthen connections between academia and industry, and between technology innovation and product development. The scientific session will feature an array of distinguished speakers presenting most recent advances in the life cycle of drug discovery and development. The interactive panel discussions present strategies to reinvent biopharma R&D business model with the aim to enhance efficiency and success rate from both regional and global perspectives. Through a format of knowledge sharing and networking, the goal is to promote innovation, collaboration, and support advancement of San Diego’s biopharmaceutical research and development.

8:00 am  -   5:00 pm Exhibition
8:00 am  -   8:45 am Continental Breakfast & Registration
8:45 am  -   9:00 am Welcome
9:00 am  -  10:00 am Session I. Collaborative R&D-Industry and Academia

Diego Miralles, Head and Chief Medical Officer, J&J PRD West Coast (confirmed)

Xiaodong Wang, Director, National Institute of Biological Sciences, Beijing China (confirmed)
10:00 am  -  10:30 am Coffee Break
10:300 am  -  12:00 pm Session II (Plenary Discussion). Emerging Fields and Adapting Strategies

Moderator : Lewis Shuster, CEO, Shuster Capitals (confirmed)

John Dunn, Executive Vice President, New Ventures, Biogen-Idec (confirmed)

Greg Heath, Sr. VP & General Manager, Diagnostics Business Unit, Illumina (confirmed)

Steve Kaldor, President and CEO, Ambrx (confirmed)

Bob More, General Partner, Frazier Healthcare Ventures (confirmed)

Richard Neale, Chief Business Officer, Scripps Translational Science Institute (confirmed)
12:00 pm  -  1:30 pm Luncheon
1:15 pm  -   2:00 pm San Diego Bio-Pharma Achievement Award

Award Recipient : Ge Li, Ge Li, CEO, WuXi AppTech (confirmed)
2:00 pm  -   3:00 pm Session III. Drug Discovery in a Global Setting

Steve Yang, Vice President, Head of R&D, Asia at Pfizer (confirmed)

Troy Wilson, President and CEO, Intellikine (confirmed)
3:00 pm  -   3:30 pm Coffee Break (/B)
3:30 pm  -   4:45 pm Session IV (Plenary Discussion). Pharmaceutical Development in China <!--br> Description: The recent swine flu outbreak is a reminder that infectious diseases represent an ongoing threat to public health. This distinguished panel of researchers, executives, and regulatory experts will offer insight into the lessons that can be learned by examining the swine flu outbreak as a case study. The audience will gain a new appreciation for the challenges presented in identifying and responding to the apparent spread of a disease. The panelists will discuss cutting-edge approaches for diagnosis, DNA vaccine and antiviral agents. Learn how the CDC and FDA have worked with private industry to ensure that public health needs are addressed in an expedited manner to combat the outbreak of disease. The panelists' insights will be illuminating for anyone with an interest in emerging infectious diseases.

Moderator : John Oyler (confirmed)

Nancy Chang, Senior Managing Director, Asia and Chairperson of the Asia team, OrbiMed (confirmed)

James Tong, CFO, Chief Business & Development Officer, Tianyin Pharmaceutical, China (confirmed)

Xiaodong Wang, Director, National Institute of Biological Sciences, Beijing China (confirmed)

Steve Yang, Vice President, Head of R&D, Asia at Pfizer (confirmed)

Guo-Liang Yu, President, CEO and Chairman of the Board, Epitomics (confirmed)
4:45 pm Closing

 

Preliminary program as of April 26, 2010.   All events will take place at Hilton San Diego/Del Mar , Del Mar.

Registration


USA Field Hockey Three Nation Series

 

La Jolla Symphony & Chorus Concert

 

Support ACCEF, Make A World Difference!

 

Events Before 2010